Industry Reports
Abbott reports third-quarter 2013 results
Abbott today announced financial results for the third quarter ended Sept. 30, 2013. Third-quarter 2013 worldwide sales of $5.4 billion increased 4.3 percent on an...
Industry Reports
Adocia announces its Q1 2013 revenues
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today its Q1 2013 revenues. ...
Industry Reports
Bristol-Myers Squibb reports first quarter 2013 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported financial results for the first quarter of 2013, and confirmed GAAP EPS and non-GAAP EPS guidance ranges for...
Industry Reports
Abbott reports first-quarter 2013 results
Abbott announced financial results for the first quarter ended March 31, 2013. Worldwide sales of nearly $5.4 billion increased 3.5 percent on an operational...
Industry Reports
Bristol-Myers Squibb to Announce Results for First Quarter 2013 on April 25
Bristol-Myers Squibb Company will announce results for the first quarter of 2013 on Thursday April 25 2013. During a conference call at 10:30 a.m....
Industry Reports
A strong cash position of EUR 30.5 million, an annual loss of EUR 6.0 million and significant clinical progress of Adocia projects
Adocia, a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today its financial results for 2012. ...
Industry Reports
Adocia reports 2012 revenue multiplied by 2.5 with a strong cash position
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already approved therapeutic proteins, announces today its revenue for the full...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.